Ultrabright NIR-II fluorophores enabled by noncovalent conformational locking for in vivo inflammation imaging
Ultrabright fluorophores emitting in the second near-infrared (NIR-II, 1000–1700 nm) window are highly desirable for biomedical and optoelectronic applications but remain rare, because fluorescence brightness requires the simultaneous realization of a large absorption coefficient (ε) and a high photoluminescence quantum yield (Φ PL ), two parameters that are inherently difficult to balance. Here, we develop an ultrabright semiconducting polymer fluorophore (P1) via a simple noncovalent conformational locking strategy that enforces a rigid and planar backbone with small dihedral angles. This design extends π-conjugation to boost ε and Φ PL while effectively suppressing aggregation-caused quenching in P1 nanoparticles (P1 NPs). Compared to its unlocked analogue, P1 NPs exhibits a notable 360 nm redshift towards NIR-II emission, together with intensified ε and elevated Φ PL . These properties afford P1 NPs 10-fold enhancement in NIR-II brightness relative to reported polymer fluorophores, enabling high-resolution vascular imaging and precise inflammation localization. These findings represent a significant design advance in creating ultrabright fluorophores for bioimaging and optoelectronic applications.
Authors
- Zizi Wu
- Quli Fan (ORCID: https://orcid.org/0000-0002-9387-0165)
- Wenbo Hu (ORCID: https://orcid.org/0000-0001-5233-8183)
- Xiaofei Miao
- Weiyun Yao
- Xiaomei Lu (ORCID: https://orcid.org/0009-0003-4071-0795)
- Ruizhe Chen (ORCID: https://orcid.org/0009-0001-4797-6436)
- Mingxuan Jia (ORCID: https://orcid.org/0009-0004-2830-7335)
Institutions
- Nanjing Tech University (CN)
- Northwestern Polytechnical University (CN)
- Nanjing University of Posts and Telecommunications (CN)
Publication Details
- Journal
- Science Advances
- Published
- 2026-09-16
- DOI
- https://doi.org/10.1126/sciadv.aeh5112
- Primary Topic
- Luminescence and Fluorescent Materials
- Type
- article
- Field-Weighted Citation Impact
- 0.00